跳至主要内容
临床试验/NCT04000945
NCT04000945Unknown不适用

Evaluation of Safety and Efficacy of the BTL-899 Device for Non-invasive Lipolysis and Circumference Reduction of Abdomen When Compared to a Sham Treatment

BTL Industries Ltd.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年12月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Occurrence of adverse events

研究概览

简要总结

The study is a prospective single-blinded two-arms study that includes three treatment procedures and four follow-up visits

详细描述

This study will evaluate the clinical efficacy and safety of the BTL-899 device for non-invasive lipolysis and circumference reduction of abdomen. The study is a prospective single-blinded two-arms study. The subjects will be enrolled and assigned into a two study groups. All subjects will complete three (3) treatment visits and will be invited to four (4) follow-up visits 1, 2, 3 and 6-months after the final treatment. 6-months follow-up visit is the optional one.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 21 years
  • Voluntarily signed informed consent form
  • BMI ≤ 35 kg/m2
  • Women of child-bearing potential are required to use birth control measures during the whole duration of the study
  • Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation
  • Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation

排除标准

  • Cardiac pacemakers
  • Cardiovascular diseases
  • Implanted defibrillators, implanted neurostimulators
  • Electronic implants
  • Disturbance of temperature or pain perception
  • Pulmonary insufficiency
  • Metal implants
  • Drug pumps
  • Malignant tumor
  • Hemorrhagic conditions
  • Septic conditions and empyema
  • Acute inflammations
  • Systemic or local infection such as osteomyelitis and tuberculosis
  • Contageous skin disease
  • Elevated body temperature
  • Pregnancy
  • Breastfeeding
  • Injured or otherwise impaired muscles
  • Scars, open lesions and wounds at the treatment area
  • Basedow's disease
  • Previous liposuction in the treatment area in the last six months
  • Abdominal wall diastasis
  • Unstable weight within the last 6 months
  • Previous body contouring treatments in the abdomen area in the last three months

研究组 & 干预措施

BTL-899 Therapy Arm

Experimental

干预措施: BTL-899 (Device)

Sham Arm

Sham Comparator

干预措施: Sham (Device)

结局指标

主要结局

Occurrence of adverse events

时间窗: 7 months

The occurrence of adverse events will be followed throughout the whole study.

Efficacy of the BTL-899 treatment for change in abdominal circumference

时间窗: 4 months

Comparison of change in abdominal circumference at the final follow-up visit between two study groups.

次要结局

  • Efficacy of BTL-899 treatment for abdominal fat and circumference reduction, as assessed by two blinded evaluators(4 months)
  • Efficacy of the BTL-899 treatment for change in abdominal circumference(4 months)
  • Efficacy of the BTL-899 treatment for abdominal fat reduction(4 months)
  • Subject's satisfaction with study treatment(4 months)
  • Therapy comfort during the study treatment.(1 month)

研究者

发起方
BTL Industries Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验